Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Review the data published on the subject to create a more comprehensive natural history of intraventricular meningiomas (IVMs). A Medline search up to March 2018 using "intraventricular meningioma" returned 98 papers. As a first selection step, we adopted the following inclusion criteria: series and case reports about IVMs, as well as papers written in other languages, but abstracts written in English were evaluated. Six hundred eighty-one tumors were evaluated from 98 papers. The majority of the tumors were located in the lateral ventricles (602-88.4%), fourth ventricle (59-8.7%), and third ventricle (20-2.9%). These tumors accounted for a mortality rate of 4.0% (25 deaths) and a recurrence rate of 5.3% (26 recurrences). The majority of the tumors were grade I (89.8%) and consisted of the following subtypes: fibrous, 39.7% (n = 171); transitional, 22.0% (n = 95); meningothelial, 18.6% (n = 80); angiomatosus, 3.2% (n = 14); psammomatous, 2.6% (n = 11); and others, 13.9% (n = 60). Forty-five patients (7.4%) presented with grade II (GII) tumors, and 17 patients (2.8%) presented with grade III (GIII) tumors. These tumors follow the histopathological distribution of meningiomas in general, with the exception of the higher prevalence of the fibrous subtype, possibly due to its embryonic origin. Recurrence and mortality were lower than in other localizations likely due to a complete surgical resection rate than in the convexity and skull base, which suggests that GTR is the gold standard for the management of IVMs.
Review the data published on the subject to create a more comprehensive natural history of intraventricular meningiomas (IVMs). A Medline search up to March 2018 using "intraventricular meningioma" returned 98 papers. As a first selection step, we adopted the following inclusion criteria: series and case reports about IVMs, as well as papers written in other languages, but abstracts written in English were evaluated. Six hundred eighty-one tumors were evaluated from 98 papers. The majority of the tumors were located in the lateral ventricles (602-88.4%), fourth ventricle (59-8.7%), and third ventricle (20-2.9%). These tumors accounted for a mortality rate of 4.0% (25 deaths) and a recurrence rate of 5.3% (26 recurrences). The majority of the tumors were grade I (89.8%) and consisted of the following subtypes: fibrous, 39.7% (n = 171); transitional, 22.0% (n = 95); meningothelial, 18.6% (n = 80); angiomatosus, 3.2% (n = 14); psammomatous, 2.6% (n = 11); and others, 13.9% (n = 60). Forty-five patients (7.4%) presented with grade II (GII) tumors, and 17 patients (2.8%) presented with grade III (GIII) tumors. These tumors follow the histopathological distribution of meningiomas in general, with the exception of the higher prevalence of the fibrous subtype, possibly due to its embryonic origin. Recurrence and mortality were lower than in other localizations likely due to a complete surgical resection rate than in the convexity and skull base, which suggests that GTR is the gold standard for the management of IVMs.
S Clozapine Hypomania: case reportA 54-year-old woman developed hypomania while receiving clozapine for schizophrenia.The woman had a history of a surgically removed intraventricular meningioma, and was admitted for treatment of a urinary tract infection with fever. Because of prominent positive and negative symptoms, she was started on clozapine at an initial dosage of 50 mg/day, titrated up to 150 mg/day [route not stated]. Once the fever had resolved, she was transferred to a psychiatric ward due to behavioural disturbances, and referential and persecutory delusions. Clozapine was titrated up to 200 mg/day on day 6. Over the next 4 days, she experienced an exacerbation of agitation and psychotic symptoms, talkativeness, a decreased need for sleep, and hyperactivity. On day 10, clozapine was titrated up to 250 mg/day, and zolpidem was added for insomnia. The following night, she became more agitated, hyperactive and talkative at night. Delirium and mania were both considered.The woman's zolpidem was withdrawn, and the clozapine dosage was tapered to 100 mg/day. She gradually became avolitional and displayed poor self-care. Clozapine was titrated up to 150 mg/day on day 23 because of the prominent negative symptoms. There was a recurrence of manic symptoms, with hyperactivity, euphoria, inflated self-esteem, an argumentative attitude and increased talkativeness. Clozapine was tapered down to 125 mg/day, and she became euthymic. Her negative symptoms substantially improved without mania. She has been successfully maintained on clozapine for more than 1 year.Author comment: "We present the case of a schizophrenic patient with a history of meningioma who developed mania while receiving clozapine". Li T-M, et al. Low-dose clozapine exacerbates and then improves mood in a patient with schizophrenia and history of surgical removal of an intraventricular meningioma. Journal of Clinical Psychopharmacology 32: 835-836, No. 6, Dec 2012. Available from: URL: http://dx.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.